SHPH· Health Care› Drug Manufacturers - Specialty & Generic

Shuttle Pharmaceuticals Holdings, Inc.

Stage 1 · Basing · week 4

As of Oct 22, 2026, Shuttle Pharmaceuticals Holdings is in Stage 1, the basing phase, now in week 4 (since Sep 28, 2026). It closed at $4.61, 85.7% below its 52-week high and below its 200-day average, which is falling.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. More about the company

$4.61

-2.33% today

$22.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is SHPH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 36w

S4 61w

S4 46w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 36w → S1 11w → S4 2w → S1 2w → S4 61w → S1 4w → S4 46w → S1 4w current

Total tracked: 166 weeks across 8 stage runs.

SHPH among Drug Manufacturers - Specialty & Generic77th of 84 by relative strength

All 84 →

Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CPIXCumberland Pharmaceuticals Inc.	Stage 2 · wk 23	98	+6.8%
2	ETONEton Pharmaceuticals, Inc.	Stage 2 · wk 30	97	−10.1%
3	ANIKAnika Therapeutics Inc.	Stage 2 · wk 15	96	+3.5%
4	IRWDIronwood Pharmaceuticals, Inc. Class A	Stage 3 · wk 3	96	−16.4%
5	TEVATeva Pharmaceutical Industries Limited	Stage 2 · wk 9	95	+3.1%
6	AMRXAmneal Pharmaceuticals, Inc. Class A	Stage 2 · wk 19	95	+5.9%
7	KNSAKiniksa Pharmaceuticals International, plc Class A	Stage 2 · wk 73	95	+6.2%
8	AMLXAmylyx Pharmaceuticals, Inc.	Stage 2 · wk 15	93	−6.6%
…77	SHPHShuttle Pharmaceuticals Holdings, Inc.	Stage 1 · wk 4	8	+28.4%

vs 52W High

-85.7%

$2.78 lo$32.20 hi

85.7% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 4

1w13w26w

Week 4, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-37.7%

200 DMA: $7.40 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.21x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+28.4%

+59.5%

-50.9%

YTD

-74.5%

-86.7%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S1

Wk 4 · Vol 0.21x

2026-10-21S1

Wk 4 · Vol 0.12x

2026-10-20S1

Wk 4 · Vol 0.14x

2026-10-19S1

Wk 4 · Vol 0.31x

2026-10-16S1

Wk 3 · Vol 0.26x

2026-10-15S1

Wk 3 · Vol 0.44x

2026-10-14S1

Wk 3 · Vol 0.52x

2026-10-13S1

Wk 3 · Vol 0.24x

2026-10-12S1

Wk 3 · Vol 0.15x

2026-10-09S1

Wk 2 · Vol 0.19x

2026-10-08S1

Wk 2 · Vol 1.91x

2026-10-07S1

Wk 2 · Vol 0.79x

Moving averages & range

50 DMA

$4.05

200 DMA

$7.40

52W High

$32.20

52W Low

$2.78

5D Low

$4.61

Resistance levels (recent highs)

20d High

$5.57

60d High

$5.57

120d High

$8.27

250d High

$32.00

Next resistance

+20.8%

to 20d High

ROE

-90.0%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.2

Shuttle Pharmaceuticals Holdings: quick answers

What stage is Shuttle Pharmaceuticals Holdings in?

As of Oct 22, 2026, Shuttle Pharmaceuticals Holdings (SHPH) is in Stage 1, the basing phase. It entered Stage 1 on Sep 28, 2026 and is in week 4. What the four stages mean

Is Shuttle Pharmaceuticals Holdings in an uptrend?

Not yet. Shuttle Pharmaceuticals Holdings is in Stage 1, a base that can come before an uptrend. It trades 37.7% below its 200-day average, which is falling.

How far is Shuttle Pharmaceuticals Holdings from its 52-week high?

Shuttle Pharmaceuticals Holdings closed at $4.61 on Oct 22, 2026, 85.7% below its 52-week high of $32.20. Its 52-week low is $2.78.

How has Shuttle Pharmaceuticals Holdings performed over the past year?

As of Oct 22, 2026, Shuttle Pharmaceuticals Holdings is down 86.7% over the past year and down 74.5% so far in 2026.

Which sector and industry is Shuttle Pharmaceuticals Holdings in?

Shuttle Pharmaceuticals Holdings is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.